JP2001521549A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521549A5
JP2001521549A5 JP1998545358A JP54535898A JP2001521549A5 JP 2001521549 A5 JP2001521549 A5 JP 2001521549A5 JP 1998545358 A JP1998545358 A JP 1998545358A JP 54535898 A JP54535898 A JP 54535898A JP 2001521549 A5 JP2001521549 A5 JP 2001521549A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998545358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001521549A (ja
Filing date
Publication date
Priority claimed from US08/840,608 external-priority patent/US5888998A/en
Application filed filed Critical
Publication of JP2001521549A publication Critical patent/JP2001521549A/ja
Publication of JP2001521549A5 publication Critical patent/JP2001521549A5/ja
Ceased legal-status Critical Current

Links

JP54535898A 1997-04-24 1998-04-23 強力なβ−ラクタマーゼ阻害剤としての２−オキソ−１−アゼチジンスルホン酸誘導体 Ceased JP2001521549A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/840,608 US5888998A (en) 1997-04-24 1997-04-24 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
US08/840,608 1997-04-24
PCT/IB1998/000622 WO1998047895A1 (en) 1997-04-24 1998-04-23 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT β-LACTAMASE INHIBITORS

Publications (2)

Publication Number Publication Date
JP2001521549A JP2001521549A (ja) 2001-11-06
JP2001521549A5 true JP2001521549A5 (enExample) 2005-12-02

Family

ID=25282793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54535898A Ceased JP2001521549A (ja) 1997-04-24 1998-04-23 強力なβ−ラクタマーゼ阻害剤としての２−オキソ−１−アゼチジンスルホン酸誘導体

Country Status (10)

Country Link
US (1) US5888998A (enExample)
EP (1) EP0979229B1 (enExample)
JP (1) JP2001521549A (enExample)
KR (1) KR20010020181A (enExample)
AU (1) AU740446B2 (enExample)
CA (1) CA2287219C (enExample)
DE (1) DE69808901T2 (enExample)
HU (1) HUP0001269A3 (enExample)
NO (1) NO995108L (enExample)
WO (1) WO1998047895A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010002705A (ko) * 1999-06-17 2001-01-15 고두모 신규 티아졸 초산의 반응성 포스페이트 유도체의 제조방법
DK1322648T3 (da) 2000-09-14 2005-10-31 Pantherix Ltd 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
CA2629570C (en) * 2005-12-07 2012-11-27 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
KR101320718B1 (ko) 2007-03-23 2013-10-21 바실리어 파마슈티카 아게 세균 감염 치료용 조합 약제
EP2603514B1 (en) 2010-08-10 2018-07-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
US8806158B2 (en) 2010-09-22 2014-08-12 International Business Machines Corporation Intelligent computer memory management
US9012491B2 (en) 2011-08-31 2015-04-21 Rempex Pharmaceuticals, Inc. Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
US9156858B2 (en) 2012-05-23 2015-10-13 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US10561675B2 (en) 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
CN103435650B (zh) * 2012-12-28 2015-12-02 南京海融医药科技有限公司 单环β-内酰胺类化合物、制备方法及其制药用途
JP2016509594A (ja) 2013-01-04 2016-03-31 レンペックス・ファーマシューティカルズ・インコーポレイテッド ボロン酸誘導体及びその治療的使用
US9101638B2 (en) 2013-01-04 2015-08-11 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US9241947B2 (en) 2013-01-04 2016-01-26 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
AU2014204046B2 (en) 2013-01-04 2017-02-23 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
RS59488B1 (sr) 2014-05-05 2019-12-31 Rempex Pharmaceuticals Inc Sinteza boronatnih soli i njihove upotrebe
US9687497B1 (en) 2014-05-05 2017-06-27 Rempex Pharmaceuticals, Inc. Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
MX2016015093A (es) 2014-05-19 2017-03-27 Rempex Pharmaceuticals Inc Derivados de acido boronico y sus usos terapeuticos.
EA201692301A1 (ru) 2014-07-01 2017-06-30 Ремпекс Фармасьютикалз, Инк. Производные бороновой кислоты и их терапевтическое применение
US10662205B2 (en) 2014-11-18 2020-05-26 Qpex Biopharma, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2016100043A1 (en) 2014-12-19 2016-06-23 Rempex Pharmaceuticals, Inc. Apparatus and continuous flow process for production of boronic acid derivatives
US20180051041A1 (en) 2015-03-17 2018-02-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
RU2618433C2 (ru) * 2015-08-10 2017-05-03 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) Антимикробная комбинация в отношении устойчивых к карбапенемам грамотрицательных бактерий вида pseudomonas aeruginosa, продуцирующих металло-β-лактамазу
EP3478693B1 (en) 2016-06-30 2021-07-21 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof
CN107641119B (zh) * 2016-07-21 2019-11-08 中国科学院上海药物研究所 单环β-内酰胺-铁载体轭合物及其制备方法和用途
RU2666619C2 (ru) * 2016-12-01 2018-09-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ) АНТИМИКРОБНАЯ КОМБИНАЦИЯ В ОТНОШЕНИИ УСТОЙЧИВЫХ К КАРБАПЕНЕМАМ ГРАМОТРИЦАТЕЛЬНЫХ БАКТЕРИЙ ВИДА ACINETOBACTER BAUMANNII, ПРОДУЦИРУЮЩИХ МЕТАЛЛО-β-ЛАКТАМАЗУ
RU2664434C2 (ru) * 2016-12-01 2018-08-17 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ) АНТИМИКРОБНАЯ КОМБИНАЦИЯ В ОТНОШЕНИИ УСТОЙЧИВЫХ К КАРБАПЕНЕМАМ ГРАМОТРИЦАТЕЛЬНЫХ БАКТЕРИЙ ВИДА KLEBSIELLA PNEUMONIAE, ПРОДУЦИРУЮЩИХ МЕТАЛЛО-β-ЛАКТАМАЗУ
JP7377545B2 (ja) 2017-10-11 2023-11-10 キューペックス バイオファーマ， インコーポレイテッド ボロン酸誘導体およびその合成
CA3097127A1 (en) 2018-04-20 2019-10-24 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4632985A (en) * 1985-06-03 1986-12-30 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
JPH02502455A (ja) * 1987-02-27 1990-08-09 ジ・アップジョン・カンパニー ピリドンカルボン酸または酸誘導体を含有する抗生物質β‐ラクタム
US5112968A (en) * 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
CA2024282A1 (en) * 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics

Similar Documents

Publication Publication Date Title
JP2000509635A5 (enExample)
JP2000509942A5 (enExample)
JP2000509637A5 (enExample)
JP2000510751A5 (enExample)
JP2002505590A5 (enExample)
JP2001510585A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2002504852A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2002503343A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2001521549A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2000508102A5 (enExample)
JP2000508836A5 (enExample)
JP2001511981A5 (enExample)
JP2000509520A5 (enExample)
JP2001508792A5 (enExample)
JP2002501568A5 (enExample)